Krka, d. d.
KRK
Rang in Aktien
#2138
Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved... Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved in the research, production, promotion, and sale of various pharmaceutical goods. Its market presence spans Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and numerous other international territories. The company's offerings are categorized into prescription medications, over-the-counter products, and veterinary health solutions. Its prescription drug pipeline targets a broad spectrum of medical conditions, including cardiovascular disorders, gastrointestinal issues, central nervous system ailments, pain management, anti-infective treatments, conditions affecting blood and blood-forming organs, urological problems, diabetes, and oncology. The array of non-prescription items includes products for oral and throat care, cough and cold remedies, analgesics, nasal preparations, vitamin and mineral supplements, products designed to enhance cerebral and peripheral circulation, digestive aids, and various general healthcare products. Furthermore, Krka supplies animal health products such as anti-infectives, antiparasitics, and other specialized formulations for both livestock and companion animals. Beyond its pharmaceutical operations, the company also provides health resort and tourist services. Krka, d. d. was established in 1954 and has its corporate headquarters in Novo Mesto, Slovenia.
Aktienkurs
$315.87
Marktkapitalisierung
$9.56B
Veränderung (1 Tag)
0.90%
Veränderung (1 Jahr)
28.29%
Land
SI
Handel Krka, d. d. (KRK)
Kategorie
Healthcare
Umsatz von Krka, d. d. (KRK)
Umsatz im Jun 2026 TTM: $2.51B
Laut den aktuellen Finanzberichten von Krka, d. d. beträgt der derzeitige Umsatz des Unternehmens (TTM) $2.51B. Im Jahr 2023 erzielte das Unternehmen einen Umsatz von $2.00B eine Steigerung gegenüber dem Umsatz im Jahr 2022, der $1.84B betrug. Der Umsatz ist der Gesamtbetrag, den ein Unternehmen durch den Verkauf von Waren oder Dienstleistungen erzielt. Im Gegensatz zum Gewinn werden keine Ausgaben abgezogen.
Umsatzverlauf für Krka, d. d. von 2010 bis 2026
Umsatz am Ende jedes Jahres
| Jahr | Umsatz | ändert |
|---|---|---|
| 2026 (TTM) | $2.51B | 26.24% |
| 2024 | $1.99B | -0.50% |
| 2023 | $2.00B | 8.39% |
| 2022 | $1.84B | 3.47% |
| 2021 | $1.78B | -4.75% |
| 2020 | $1.87B | 11.56% |
| 2019 | $1.68B | 9.48% |
| 2018 | $1.53B | 0.72% |
| 2017 | $1.52B | 22.97% |
| 2016 | $1.24B | -2.28% |
| 2015 | $1.26B | -12.29% |
| 2014 | $1.44B | -12.69% |
| 2013 | $1.65B | 9.50% |
| 2012 | $1.51B | 8.31% |
| 2011 | $1.39B | 3.11% |
| 2010 | $1.35B | 0.00% |
Umsatz vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Umsatz | Umsatzunterschied | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 163.59% |
IN
|
